Approval · Notice of Compliance 30566 · 2023
MINT-FINASTERIDE: Notice of Compliance 30566
Issued April 25, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30566
- Date
- April 25, 2023
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- PROPECIA (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-FINASTERIDE | 02537427 | Marketed |
Medicinal ingredients
- FINASTERIDE 1 MG per TAB